Back |
home / stock / acrs / acrs message board
Subject | By | Source | When |
---|---|---|---|
Need to push thru 1.50$ today | stock1ace1 | investorshub | 10/15/2019 11:41:25 AM |
Great News !! | Timetravelerdos | investorshub | 10/14/2019 9:39:55 PM |
agree```` will hope by | toybaby | investorshub | 10/14/2019 5:47:36 PM |
Some big $ on bids ! Going up | stock1ace1 | investorshub | 10/14/2019 5:34:54 PM |
Slow n steady :) shorts will cover end | stock1ace1 | investorshub | 10/14/2019 5:01:28 PM |
WOW!! | toybaby | investorshub | 10/14/2019 4:55:50 PM |
1.50 :-D | Crazy Money | investorshub | 10/14/2019 4:48:06 PM |
*** Short Squeeze **** | stock1ace1 | investorshub | 10/14/2019 1:39:46 PM |
Gap at 3$ - $4.32 area | stock1ace1 | investorshub | 10/14/2019 11:46:54 AM |
1.44 p/m | stock1ace1 | investorshub | 10/14/2019 11:11:04 AM |
Acrs already cutting staff saving $$ Aclaris is | stock1ace1 | investorshub | 10/13/2019 8:38:00 PM |
Did anybody looks at this chart ~> https://finviz.com/quote.ashx?t=$ACRS Can | stock1ace1 | investorshub | 10/13/2019 7:43:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
- Progressing ATI-2138 into Atopic Dermatitis - - Management to Host Conference Call at 5:00 PM ET Today - WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidat...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
BioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. T...